Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Risk factors for advanced liver fibrosis in HIV-infected individuals: role of antiretroviral drugs and insulin resistance.

Blanco F, Barreiro P, Ryan P, Vispo E, Martín-Carbonero L, Tuma P, Labarga P, Medrano J, González-Lahoz J, Soriano V.

J Viral Hepat. 2011 Jan;18(1):11-6. doi: 10.1111/j.1365-2893.2009.01261.x.

PMID:
20088890
2.

Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus.

Berenguer J, Alvarez-Pellicer J, Martín PM, López-Aldeguer J, Von-Wichmann MA, Quereda C, Mallolas J, Sanz J, Tural C, Bellón JM, González-García J; GESIDA3603/5607 Study Group.

Hepatology. 2009 Aug;50(2):407-13. doi: 10.1002/hep.23020.

PMID:
19575364
3.

Cryptogenic liver disease in HIV-seropositive men.

Dinh MH, Stosor V, Rao SM, Miller FH, Green RM.

HIV Med. 2009 Aug;10(7):447-53. doi: 10.1111/j.1468-1293.2009.00712.x. Epub 2009 May 6.

4.

Influence of insulin resistance on hepatic fibrosis and steatosis in hepatitis C virus (HCV) mono-infected compared with HIV-HCV co-infected patients.

Halfon P, Pénaranda G, Carrat F, Bedossa P, Bourlière M, Ouzan D, Renou C, Tran A, Rosenthal E, Wartelle C, Delasalle P, Cacoub P.

Aliment Pharmacol Ther. 2009 Jul;30(1):61-70. doi: 10.1111/j.1365-2036.2009.03995.x. Epub 2009 Mar 9.

5.

Impact of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis.

Deng LP, Gui XE, Zhang YX, Gao SC, Yang RR.

World J Gastroenterol. 2009 Feb 28;15(8):996-1003.

6.

Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis.

Thein HH, Yi Q, Dore GJ, Krahn MD.

AIDS. 2008 Oct 1;22(15):1979-91. doi: 10.1097/QAD.0b013e32830e6d51. Review.

PMID:
18784461
7.

Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe.

Soriano V, Mocroft A, Rockstroh J, Ledergerber B, Knysz B, Chaplinskas S, Peters L, Karlsson A, Katlama C, Toro C, Kupfer B, Vogel M, Lundgren J; EuroSIDA Study Group.

J Infect Dis. 2008 Nov 1;198(9):1337-44. doi: 10.1086/592171.

PMID:
18767985
8.

Steatohepatitis: Risk factors and impact on disease severity in human immunodeficiency virus/hepatitis C virus coinfection.

Sterling RK, Contos MJ, Smith PG, Stravitz RT, Luketic VA, Fuchs M, Shiffman ML, Sanyal AJ.

Hepatology. 2008 Apr;47(4):1118-27. doi: 10.1002/hep.22134.

9.

Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcome.

Castellares C, Barreiro P, Martín-Carbonero L, Labarga P, Vispo ME, Casado R, Galindo L, García-Gascó P, García-Samaniego J, Soriano V.

J Viral Hepat. 2008 Mar;15(3):165-72. doi: 10.1111/j.1365-2893.2007.00903.x.

PMID:
18233989
10.

Liver fibrosis on account of chronic hepatitis C is more severe in HIV-positive than HIV-negative patients despite antiretroviral therapy.

de Lédinghen V, Barreiro P, Foucher J, Labarga P, Castéra L, Vispo ME, Bernard PH, Martin-Carbonero L, Neau D, García-Gascó P, Merrouche W, Soriano V.

J Viral Hepat. 2008 Jun;15(6):427-33. doi: 10.1111/j.1365-2893.2007.00962.x. Epub 2008 Jan 22.

PMID:
18221303
11.

Identification of liver fibrosis in HIV/HCV-coinfected patients using a simple predictive model based on routine laboratory data.

Berenguer J, Bellón JM, Miralles P, Alvarez E, Sánchez-Conde M, Cosín J, López JC, Alvarez F, Catalán P, Resino S.

J Viral Hepat. 2007 Dec;14(12):859-69. Erratum in: J Viral Hepat. 2008 Feb;15(2):156.

PMID:
18070289
12.

Clinical progression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapy.

Pineda JA, García-García JA, Aguilar-Guisado M, Ríos-Villegas MJ, Ruiz-Morales J, Rivero A, del Valle J, Luque R, Rodríguez-Baño J, González-Serrano M, Camacho A, Macías J, Grilo I, Gómez-Mateos JM; Grupo para el Estudio de las Hepatitis Víricas de la Sociedad Andaluza de Enfermedades Infecciosas (SAEI).

Hepatology. 2007 Sep;46(3):622-30.

PMID:
17659577
13.

Regression of liver fibrosis in hepatitis C virus/HIV-co-infected patients after treatment with pegylated interferon plus ribavirin.

Soriano V, Labarga P, Ruiz-Sancho A, Garcia-Samaniego J, Barreiro P.

AIDS. 2006 Nov 14;20(17):2225-7. No abstract available.

PMID:
17086063
14.

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection.

Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, S Sulkowski M, Torriani FJ, Dieterich DT, Thomas DL, Messinger D, Nelson M; APRICOT Clinical Investigators.

Hepatology. 2006 Jun;43(6):1317-25.

PMID:
16729309
15.

Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients.

de Lédinghen V, Douvin C, Kettaneh A, Ziol M, Roulot D, Marcellin P, Dhumeaux D, Beaugrand M.

J Acquir Immune Defic Syndr. 2006 Feb 1;41(2):175-9.

PMID:
16394849
16.

Is there evidence for an increase in the death rate from liver-related disease in patients with HIV?

Mocroft A, Soriano V, Rockstroh J, Reiss P, Kirk O, de Wit S, Gatell J, Clotet B, Phillips AN, Lundgren JD; EuroSIDA Study Group.

AIDS. 2005 Dec 2;19(18):2117-25.

PMID:
16284461
17.

Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy.

Bräu N, Salvatore M, Ríos-Bedoya CF, Fernández-Carbia A, Paronetto F, Rodríguez-Orengo JF, Rodríguez-Torres M.

J Hepatol. 2006 Jan;44(1):47-55. Epub 2005 Jul 27.

PMID:
16182404
18.

Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple non-invasive indexes.

Macías J, Girón-González JA, González-Serrano M, Merino D, Cano P, Mira JA, Arizcorreta-Yarza A, Ruíz-Morales J, Lomas-Cabeza JM, García-García JA, Corzo JE, Pineda JA.

Gut. 2006 Mar;55(3):409-14. Epub 2005 Aug 23.

19.

HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis.

Pineda JA, Romero-Gómez M, Díaz-García F, Girón-González JA, Montero JL, Torre-Cisneros J, Andrade RJ, González-Serrano M, Aguilar J, Aguilar-Guisado M, Navarro JM, Salmerón J, Caballero-Granado FJ, García-García JA; Grupo Andaluz para el Estudio de las Enfermedades Infecciosas; Grupo Andaluz para el Estudio del Hígado.

Hepatology. 2005 Apr;41(4):779-89.

PMID:
15800956
20.

Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C.

Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F, de Lédinghen V, Marcellin P, Dhumeaux D, Trinchet JC, Beaugrand M.

Hepatology. 2005 Jan;41(1):48-54.

PMID:
15690481

Supplemental Content

Support Center